Lucid Diagnostics Inc. (LUCD) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Lucid Diagnostics Inc. (LUCD) Bundle
Gain insights into your Lucid Diagnostics Inc. (LUCD) valuation analysis with our cutting-edge DCF Calculator! Preloaded with real LUCD data, this Excel template enables you to adjust forecasts and assumptions to accurately determine Lucid Diagnostics Inc.'s intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .5 | .4 | 2.4 | 2.9 | 3.4 | 4.1 | 4.8 | 5.8 |
| Revenue Growth, % | 0 | 0 | 0 | -24.6 | 544.03 | 18.85 | 18.85 | 18.85 | 18.85 | 18.85 |
| EBITDA | .0 | .0 | -27.4 | -54.2 | -49.8 | -.6 | -.7 | -.8 | -1.0 | -1.2 |
| EBITDA, % | 100 | 100 | -5483 | -14385.94 | -2049.05 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | 4.4 | 8.3 | .0 | 1.9 | 2.5 | 2.3 | 2.7 | 3.3 | 3.9 | 4.6 |
| Depreciation, % | 100 | 100 | 0.8 | 513.53 | 102.92 | 80.16 | 80.16 | 80.16 | 80.16 | 80.16 |
| EBIT | -4.4 | -8.3 | -27.4 | -56.2 | -52.3 | -.6 | -.7 | -.8 | -1.0 | -1.2 |
| EBIT, % | 100 | 100 | -5483.8 | -14899.47 | -2151.98 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | .2 | .1 | 53.7 | 22.5 | 18.9 | 2.9 | 3.4 | 4.1 | 4.8 | 5.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .2 | .0 | .0 | 1.4 | 1.7 | 2.0 | 2.4 | 2.8 |
| Account Receivables, % | 100 | 100 | 40 | 4.51 | 1.85 | 49.27 | 49.27 | 49.27 | 49.27 | 49.27 |
| Inventories | .0 | .8 | .5 | .1 | .3 | 2.0 | 2.3 | 2.8 | 3.3 | 3.9 |
| Inventories, % | 100 | 100 | 98.6 | 29.44 | 11.45 | 67.9 | 67.9 | 67.9 | 67.9 | 67.9 |
| Accounts Payable | .8 | 2.1 | 1.5 | 1.1 | 1.1 | 2.6 | 3.1 | 3.6 | 4.3 | 5.1 |
| Accounts Payable, % | 100 | 100 | 298 | 280.11 | 47.2 | 89.44 | 89.44 | 89.44 | 89.44 | 89.44 |
| Capital Expenditure | .0 | .0 | -.9 | -.9 | -.2 | -1.2 | -1.4 | -1.7 | -2.0 | -2.4 |
| Capital Expenditure, % | 100 | 100 | -172.4 | -240.85 | -9.1 | -41.82 | -41.82 | -41.82 | -41.82 | -41.82 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -4.4 | -8.3 | -28.1 | -56.2 | -52.3 | -.6 | -.7 | -.8 | -1.0 | -1.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | .8 | .4 | -29.3 | -55.0 | -50.1 | -1.1 | .5 | .6 | .7 | .8 |
| WACC, % | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1 | |||||||||
| Terminal Value | 12 | |||||||||
| Present Terminal Value | 8 | |||||||||
| Enterprise Value | 8 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | 12 | |||||||||
| Diluted Shares Outstanding, MM | 42 | |||||||||
| Equity Value Per Share | 0.29 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled financial data for Lucid Diagnostics Inc. (LUCD).
- Real-World Data: Historical performance metrics and forward-looking projections (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC as needed.
- Automatic Calculations: Instantly observe how your inputs affect the valuation of Lucid Diagnostics Inc. (LUCD).
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step guidance.
Key Features
- Comprehensive Data: Lucid Diagnostics Inc.'s historical financial statements and pre-filled projections.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Monitor Lucid Diagnostics' intrinsic value recalculating instantly.
- Intuitive Visual Outputs: Dashboard charts showcase valuation results and essential metrics.
- Engineered for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based LUCD DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Lucid Diagnostics' intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose Lucid Diagnostics Inc. (LUCD) Calculator?
- All-in-One Solution: Combines DCF, WACC, and essential financial ratio analyses in a single platform.
- Flexible Inputs: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Lucid Diagnostics' intrinsic value and Net Present Value.
- Preloaded Information: Access historical and projected data for reliable baseline calculations.
- Expert-Level Tool: Perfect for financial professionals, investors, and business advisors.
Who Should Use This Product?
- Investors: Accurately assess Lucid Diagnostics Inc.’s (LUCD) fair value prior to making investment choices.
- CFOs: Utilize a high-quality DCF model for financial reporting and analysis related to Lucid Diagnostics Inc. (LUCD).
- Consultants: Efficiently modify the template for valuation reports tailored to clients involving Lucid Diagnostics Inc. (LUCD).
- Entrepreneurs: Acquire knowledge about financial modeling practices employed by leading healthcare companies.
- Educators: Implement it as a teaching resource to illustrate valuation techniques in the healthcare sector.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Lucid Diagnostics Inc. (LUCD) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models illustrating intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Lucid Diagnostics Inc. (LUCD).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to facilitate easy analysis of results.